BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PRANA Biotechnology Ltd 

Level 1, 100 Dorcas Street

South Melbourne  Victoria  3205  Australia
Phone: 61-3-9690-7892 Fax: 61-3-9690-8587


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
PRANA Biotechnology (PRAN) Release: The Lancet Neurology Publishes Prana's Huntington Disease Trial 11/20/2014 10:25:27 AM
PRANA Biotechnology (PRAN) Receives FDA Orphan Drug Designation For PBT2 For Huntington Disease 9/5/2014 10:26:25 AM
PRANA Biotechnology (PRAN) Alzheimer's Disease Development Program Update 7/18/2014 9:18:11 AM
World Leader In Movement Disorders Professor Ira Shoulson Joins PRANA Biotechnology (PRAN) Board 5/14/2014 6:51:17 AM
PRANA Biotechnology (PRAN) Tanks As Lead Drug Fails Alzheimer's Study 3/31/2014 7:52:55 AM
PRANA Biotechnology (PRAN) Soars As Brain Disorder Drug Succeeds In Phase 2 Trial; Stock Up +39.31% At Market Close (February 18, 2014) 2/18/2014 6:47:33 AM
PRANA Biotechnology (PRAN) Provides Update On PBT2 Alzheimer's Disease Extension Trial 12/10/2013 11:36:08 AM
PRANA Biotechnology (PRAN) Completes PBT2 Dosing In IMAGINE Alzheimer's Disease Clinical Trial 12/9/2013 11:08:50 AM
PRANA Biotechnology (PRAN)'s PBT2 Featured As A Top 10 Global Neuroscience Project 11/20/2013 11:16:04 AM
PRANA Biotechnology (PRAN) Provides Update On IMAGINE Trial And Extension Trial For Alzheimer's Disease 11/18/2013 11:23:08 AM
12345678910...